citemed.com

What It Is

CiteMed is clinical evidence and literature review software designed for the medical device industry. Based on the extracted text, its core positioning is to help companies simplify medical device regulatory compliance workflows by using a clinical evidence platform to automate literature reviews, CERs (Clinical Evaluation Reports), and post-market surveillance tasks.

Key Features and Capabilities

Based on the available information, CiteMed’s main value lies in the clinical evidence management workflow. First, it automates literature reviews, which may help reduce the manual workload of searching, screening, and organizing medical literature. Second, it supports CER preparation, a critical document in medical device compliance. Third, it covers post-market surveillance, helping teams continuously track product safety and clinical performance. The text does not further clarify whether it supports literature database integrations, AI summaries, audit trails, template management, version control, or team collaboration and approval workflows.

Pricing, Deployment, and Integrations

The extracted content does not disclose plans, pricing, free trials, demo request options, or payment methods. In terms of deployment, although it is described as a platform, it is not clear whether CiteMed is a cloud-only SaaS product, a private deployment, or a hybrid deployment. There is also no information about third-party integrations, APIs, or developer support. Before procurement, buyers should prioritize confirming whether it can connect with PubMed, literature databases, internal quality management systems, or regulatory document systems.

Security, Compliance, and Support

CiteMed targets medical device regulatory compliance, giving it a strong industry-specific positioning. However, the text does not disclose its data security measures, permission system, audit logs, encryption, backups, privacy compliance, or certifications. For medical device companies, these are key evaluation criteria for any clinical evidence platform, especially when controlled documents, clinical data, and regulatory audits are involved.

Pros, Cons, and Best-Fit Users

Its strengths are its focused use case and coverage of high-value workflows such as literature reviews, CERs, and post-market surveillance. It is well suited to regulatory affairs, clinical evaluation, and quality compliance teams at medical device companies. The downside is the lack of public information, making it difficult to assess product maturity, usability, collaboration capabilities, and total cost.

Access in China and Alternatives

The current text does not provide information about access from China, a Chinese interface, RMB payments, or local support, so china_access is considered unknown. If a China-based team wants to adopt it, they should first test network availability, review cross-border data requirements, and confirm contract and payment processes. If localization or domestic alternatives are required, they can evaluate Chinese providers of medical device clinical evaluation, regulatory document management, or quality management software.